ACI
ONC

AMP Capital Investors’s BeOne Medicines Ltd ONC Stock Holding History

AMP Capital Investors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,905
Closed -$692K – 1027
2021
Q3 		$692K Sell
1,905
-427
-18% -$140K ﹤0.01% 902
2021
Q2 		$810K Hold
2,332
– – ﹤0.01% 882
2021
Q1 		$801K Hold
2,332
– – ﹤0.01% 895
2020
Q4 		$595K Sell
2,332
-4,514
-66% -$1.24M ﹤0.01% 961
2020
Q3 		$1.93M Buy
6,846
+218
+3% +$51.2K 0.01% 724
2020
Q2 		$1.25M Sell
6,628
-1,613
-20% -$263K 0.01% 788
2020
Q1 		$1.03M Hold
8,241
– – 0.01% 783
2019
Q4 		$1.37M Sell
8,241
-102
-1% -$16.9K 0.01% 815
2019
Q3 		$1.01M Hold
8,343
– – 0.01% 872
2019
Q2 		$1.05M Buy
8,343
+2,281
+38% +$290K 0.01% 879
2019
Q1 		$767K Sell
6,062
-115
-2% -$15.5K ﹤0.01% 896
2018
Q4 		$846K Buy
+6,177
New +$819K 0.01% 871

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

AMP Capital Investors's ONC Position: Q4 2021 in Review

AMP Capital Investors sold out of BeOne Medicines Ltd (ONC) in Q4 2021, closing a stake of 1,905 shares — an estimated $692K sold.

AMP Capital Investors first reported a position in ONC in Q4 2018 and held it in 12 quarters. The position peaked at $1.93M in Q3 2020. 263 funds tracked by Wall St. Rank hold ONC as of Q4 2021.

  • AMP Capital Investors reported no remaining BeOne Medicines Ltd position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 1,905 BeOne Medicines Ltd shares in Q4 2021, an estimated $692K.
  • AMP Capital Investors first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 12 quarters.
  • AMP Capital Investors's BeOne Medicines Ltd position peaked at $1.93M in Q3 2020.
  • 263 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.